Seyoung Jung is an author at Sungkyunkwan University.
Publications per year
2024–2024
1
1
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial
Hyung‐Don Kim, Seyoung Jung, Ho Yeong Lim et al. · Nature Medicine · 2024 · 57 citations · Full text
Rows per page
1–1 of 1